MARKSANS PHARMA LTD. (MARKSANS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 153.05 182.04 204.67 241.36 225.20 254.53 308.63 311.87 299.36 319.73 320.44 339.73
YOY Revenue Growth % -13.18% 14.38% 20.21% 39.72% 47.14% 39.82% 50.79% 29.21% 32.93% 25.62% 3.83% 8.93%
Other Income 4.30 32.62 15.93 1.33 12.19 8.15 31.36 22.51 7.82 2.01 58.19 15.86
Total Income 157.35 214.66 220.60 242.69 237.39 262.68 339.98 334.37 307.17 321.74 378.63 355.59
Total Expenses + 120.60 134.07 155.71 178.74 173.04 188.96 225.93 222.96 257.27 258.17 257.14 273.47
Cost of Materials Consumed 85.36 82.80 102.83 117.16 104.36 116.12 134.73 141.27 145.06 145.28 146.66 151.00
Employee Benefit Expense 15.42 16.93 18.23 20.47 21.56 23.19 23.91 25.75 28.82 27.90 28.46 32.70
Other Expenses 19.82 34.35 34.65 41.11 47.11 49.65 67.29 55.94 55.84 56.99 54.43 58.38
Operating Profit 32.45 47.97 48.96 62.63 52.16 65.57 82.70 88.90 42.09 61.56 63.30 66.26
OPM % 21.2% 26.4% 23.9% 25.9% 23.2% 25.8% 26.8% 28.5% 14.1% 19.3% 19.8% 19.5%
Profit Before Tax + 22.85 54.40 44.50 34.60 38.40 42.30 76.34 74.72 49.90 63.57 121.49 82.12
Tax Expense 5.04 10.20 13.21 9.31 5.41 10.28 13.13 19.26 12.31 15.52 21.69 21.20
Tax % 22% 18.8% 29.7% 26.9% 14.1% 24.3% 17.2% 25.8% 24.7% 24.4% 17.9% 25.8%
Profit After Tax 17.81 44.19 31.29 25.29 32.99 32.02 63.20 55.46 37.59 48.06 99.81 60.91
EPS (Basic) 0.43 0.98 0.69 0.56 0.73 0.71 1.39 1.22 0.83 1.06 2.20 1.34

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 1,174.37 853.27 655.20 658.29 599.55 433.42 424.16
YOY Revenue Growth % 37.63% 30.23% -0.47% 9.8% 38.33% 2.18% -
Other Income 69.83 62.07 60.48 42.25 31.16 0.17 7.93
Total Income 1,244.21 915.35 715.69 700.54 630.70 433.59 432.09
Total Expenses + 1,000.95 641.55 507.34 494.97 439.22 328.10 332.63
Cost of Materials Consumed 537.18 407.15 338.49 327.99 291.29 209.20 208.14
Employee Benefit Expense 101.68 77.19 56.09 60.46 54.64 48.51 46.33
Other Expenses 228.71 157.21 112.76 106.52 93.28 70.39 78.16
Operating Profit 173.43 211.72 147.86 163.32 160.33 105.32 91.53
OPM % 14.8% 24.8% 22.6% 24.8% 26.7% 24.3% 21.6%
Profit Before Exceptional 243.26 171.89 132.04 134.51 124.33 52.73 56.01
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 243.26 171.89 132.04 134.51 124.33 52.73 56.01
Tax Expense 54.99 38.13 29.17 30.52 25.95 14.82 12.39
Tax % 22.6% 22.2% 22.1% 22.7% 20.9% 28.1% 22.1%
Profit After Tax 188.27 133.76 102.87 103.99 98.38 37.90 43.62
EPS (Basic) 4.15 2.95 2.48 2.54 2.40 0.93 1.07

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 673.08 568.33 431.10 0.00 0.00 0.00 0.00
Property, Plant & Equipment 353.59 268.51 140.88 0.00 0.00 0.00 0.00
Capital Work in Progress 0.00 0.00 3.91 0.00 0.00 0.00 0.00
Non-Current Investments 265.75 265.75 265.75 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 29.78 3.07 3.06 0.00 0.00 0.00 0.00
Current Assets + 1,082.22 947.70 913.76 0.00 0.00 0.00 0.00
Inventories 205.21 190.85 130.95 0.00 0.00 0.00 0.00
Trade Receivables 549.58 370.17 305.49 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 60.27 41.93 148.31 0.00 0.00 0.00 0.00
Current Investments 0.74 26.99 0.54 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 45.32 45.32 45.32 0.00 0.00 0.00 0.00
Other Equity 1,338.17 1,177.39 1,066.01 0.00 0.00 0.00 0.00
Non-Current Liabilities 26.18 20.90 17.00 0.00 0.00 0.00 0.00
Current Liabilities 345.64 272.44 216.54 0.00 0.00 0.00 0.00
Total Liabilities 371.82 293.33 233.54 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 31.02 34.05 51.73 50.97 0.00 0.00 0.00
Cash from Investing Activities 17.24 -114.22 -194.62 -8.40 0.00 0.00 0.00
Cash from Financing Activities -29.92 -26.22 210.02 75.86 0.00 0.00 0.00
Net Increase/Decrease in Cash 18.34 -106.38 67.12 118.44 0.00 0.00 0.00